retatrutide 2025 trial results The Effect of on Kidney Parameters in Participants With Type 2 Diabetes Mellitus and/or Obesity ADA 2026: Retatrutide Revolution

For the first time, the guidelines clearly prioritize real, minimally processed food over packaged convenience

Preserving brain structure and function , as suggested by trials like ELAD: less loss of brain volume, possibly less cognitive decline, at least in early/mild disease

GLP-1 medications are pretty remarkable

Higher doses generally lead to greater weight loss in clinical studies, but the most effective dose is the one that balances results with manageable side effects

CALL US

Its important to note that the duration of Semaglutide GLP-1 use should be personalized, as weight management is a continuous process